{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:10:56Z","timestamp":1758874256581,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10147-025-02843-w","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:56:42Z","timestamp":1753970202000},"page":"2138-2147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of vaginal cytology for postoperative surveillance of endometrial cancer"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5490-3671","authenticated-orcid":false,"given":"Yuko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-5857","authenticated-orcid":false,"given":"Eiji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-7144","authenticated-orcid":false,"given":"Tatsuo","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-8848","authenticated-orcid":false,"given":"Mamoru","family":"Kakuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-9040","authenticated-orcid":false,"given":"Satoshi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-7875","authenticated-orcid":false,"given":"Kosuke","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2787-8894","authenticated-orcid":false,"given":"Tadashi","family":"Iwamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-9994","authenticated-orcid":false,"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4876-446X","authenticated-orcid":false,"given":"Eiji","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8760-6379","authenticated-orcid":false,"given":"Yutaka","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"3","key":"2843_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2843_CR2","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, Version 2. 2023"},{"key":"2843_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","volume":"146","author":"R Salani","year":"2017","unstructured":"Salani R, Khanna N, Frimer M et al (2017) An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol 146:3\u201310","journal-title":"Gynecol Oncol"},{"issue":"9","key":"2843_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A, Bosse TJ, Creutzberg CL et al (2022) Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(9):860\u2013877","journal-title":"Ann Oncol"},{"issue":"1","key":"2843_CR5","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e18","volume":"31","author":"W Yamagami","year":"2020","unstructured":"Yamagami W, Mikami M, Nagase S et al (2020) Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms. J Gynecol Oncol 31(1):e18","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"2843_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","volume":"101","author":"M Fung-Kee-Fung","year":"2006","unstructured":"Fung-Kee-Fung M, Dodge J, Elit L et al (2006) Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 101(3):520\u2013529","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2843_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ygyno.2022.02.024","volume":"165","author":"F Siegenthaler","year":"2022","unstructured":"Siegenthaler F, Lindemann K, Epstein E et al (2022) Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification. Gynecol Oncol 165(2):230\u2013238","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2843_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3802\/jgo.2011.22.1.3","volume":"22","author":"T Odagiri","year":"2011","unstructured":"Odagiri T, Watari H, Hosaka M et al (2011) Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol 22(1):3\u201389","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2843_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","volume":"13","author":"V Kurra","year":"2013","unstructured":"Kurra V, Krajewski K, Jagannathan J et al (2013) Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging 13(1):113\u2013122","journal-title":"Cancer Imaging"},{"key":"2843_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","volume":"63","author":"LL Lin","year":"2005","unstructured":"Lin LL, Grigsby PW, Powell MA et al (2005) Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys 63:500\u2013504","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2843_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/1097-0142(19940815)74:4<1303::AID-CNCR2820740420>3.0.CO;2-G","volume":"74","author":"JD Sears","year":"1994","unstructured":"Sears JD, Greven KM, Hoen HM et al (1994) Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 74:1303\u20131308","journal-title":"Cancer"},{"key":"2843_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1525-1438.2007.00858.x","volume":"17","author":"WK Huh","year":"2007","unstructured":"Huh WK, Straughn JM Jr, Mariani A et al (2007) Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gynecol Cancer 17:886\u2013889","journal-title":"Int J Gynecol Cancer"},{"key":"2843_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","volume":"56","author":"A Jhingran","year":"2003","unstructured":"Jhingran A, Burke TW, Eifel PJ (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol 56:1366\u20131372","journal-title":"Int J Radiat Oncol"},{"key":"2843_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejca.2016.09.033","volume":"69","author":"MM Jeppesen","year":"2016","unstructured":"Jeppesen MM, Jensen PT, Gils\u00e5 Hansen D et al (2016) The nature of early-stage endometrial cancer recurrence\u2014a national cohort study. Eur J Cancer 69:51\u201360","journal-title":"Eur J Cancer"},{"issue":"4","key":"2843_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0360-3016(88)90110-1","volume":"15","author":"WJ Curran Jr","year":"1988","unstructured":"Curran WJ Jr, Whittington R, Peters AJ et al (1988) Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys 15(4):803\u2013808","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2843_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","volume":"19","author":"SM de Boer","year":"2018","unstructured":"de Boer SM, Powell ME, Mileshkin L et al (2018) Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 19:295\u2013309","journal-title":"Lancet Oncol"},{"key":"2843_CR17","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","volume":"380","author":"D Matei","year":"2019","unstructured":"Matei D, Filiaci V, Randall ME et al (2019) Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer. N Engl J Med 380:2317\u20132326","journal-title":"N Engl J Med"},{"key":"2843_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ygyno.2019.09.023","volume":"155","author":"H Nomura","year":"2019","unstructured":"Nomura H, Aoki D, Susumu N et al (2019) Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial. Gynecol Oncol 155:413\u2013419","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2843_CR19","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1097\/IGC.0000000000000797","volume":"26","author":"JY Lee","year":"2016","unstructured":"Lee JY, Kim JH, Seo JW et al (2016) Detecting asymptomatic recurrence in early-stage endometrial cancer: the value of vaginal cytology, imaging studies, and CA-125. Int J Gynecol Cancer 26(8):1434\u20131439","journal-title":"Int J Gynecol Cancer"},{"key":"2843_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0090-8258(92)90134-5","volume":"47","author":"E Podczaski","year":"1992","unstructured":"Podczaski E, Kaminski P, Gurski K et al (1992) Detection and patterns of treatment failure in 300 consecutive cases of early endometrial cancer after primary. Gynecol Oncol 47:323\u2013327","journal-title":"Gynecol Oncol"},{"key":"2843_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/gyno.1994.1282","volume":"55","author":"AG Shumsky","year":"1994","unstructured":"Shumsky AG, Stuart GCE, Brasher PM et al (1994) An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 55:229\u2013233","journal-title":"Gynecol Oncol"},{"key":"2843_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/gyno.1995.1262","volume":"59","author":"A Berchuck","year":"1995","unstructured":"Berchuck A, Anspach C, Evans AC et al (1995) Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma. Gynecol Oncol 59:20\u201324","journal-title":"Gynecol Oncol"},{"key":"2843_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/gyno.1995.0012","volume":"59","author":"J Reddoch","year":"1995","unstructured":"Reddoch J, Burke T, Morris M et al (1995) Surveillance for recurrent endometrial carcinoma: development of a follow-up. Gynecol Oncol 59:221\u2013225","journal-title":"Gynecol Oncol"},{"key":"2843_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1471-0528.1996.tb09843.x","volume":"103","author":"P Owen","year":"1996","unstructured":"Owen P, Duncan I (1996) Is there any value in the long term follow up of women treated for endometrial cancer? BJOG 103:710\u2013713","journal-title":"BJOG"},{"issue":"7","key":"2843_CR25","first-page":"879","volume":"157","author":"OO Agboola","year":"1997","unstructured":"Agboola OO, Grunfeld E, Coyle D et al (1997) Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ 157(7):879\u2013886","journal-title":"CMAJ"},{"issue":"1","key":"2843_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1479-828X.1997.tb02229.x","volume":"37","author":"TY Ng","year":"1997","unstructured":"Ng TY, Ngan HY, Cheng DK et al (1997) Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful? Aust N Z J Obstet Gynaecol 37(1):104\u2013106","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2843_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1471-0528.1997.tb10979.x","volume":"104","author":"T Salvesen","year":"1997","unstructured":"Salvesen T, Fellow R, Akslen T et al (1997) Recurrence of endometrial carcinoma and the value of routine follow up. BJOG 104:1302\u20131307","journal-title":"BJOG"},{"issue":"8","key":"2843_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","volume":"37","author":"P Morice","year":"2001","unstructured":"Morice P, Levy-Piedbois C, Ajaj S et al (2001) Value and cost evaluation of routine follow-up for patients with clinical stage I\/II endometrial cancer. Eur J Cancer 37(8):985\u2013990","journal-title":"Eur J Cancer"},{"issue":"6","key":"2843_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/IGC.0b013e31825ad3ee","volume":"22","author":"L Carrara","year":"2012","unstructured":"Carrara L, Gadducci A, Landoni F et al (2012) Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses? An Italian multicentric retrospective analysis. Int J Gynecol Cancer 22(6):1013\u20131019","journal-title":"Int J Gynecol Cancer"},{"issue":"22","key":"2843_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025863","volume":"100","author":"VD Mandato","year":"2021","unstructured":"Mandato VD, Mastrofilippo V, Palicelli A et al (2021) Solitary vulvar metastasis from early-stage endometrial cancer: case report and literature review. Medicine (Baltimore) 100(22):e25863","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2843_CR31","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s00261-020-02453-2","volume":"45","author":"A Steiner","year":"2020","unstructured":"Steiner A, Alban G, Cheng T et al (2020) Vaginal recurrence of endometrial cancer: MRI characteristics and correlation with patient outcome after salvage radiation therapy. Abdom Radiol 45(4):1122\u20131131","journal-title":"Abdom Radiol"},{"key":"2843_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0090-8258(84)90063-5","volume":"17","author":"J Aalders","year":"1984","unstructured":"Aalders J, Abeler V, Kolstad P et al (1984) Recurrent adenocarcinoma od the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17:85\u2013103","journal-title":"Gynecol Oncol"},{"issue":"40","key":"2843_CR33","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1200\/JCO.22.00471","volume":"20","author":"P Zola","year":"2022","unstructured":"Zola P, Ciccone G, Piovano E et al (2022) Effectiveness of intensive versus minimalist follow-up regimen on survival in patients with endometrial cancer (TOTEM Study): a randomized, pragmatic, parallel group, multicenter trial. J Clin Oncol 20(40):3817\u20133827","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02843-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02843-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02843-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:38:21Z","timestamp":1758872301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02843-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2843"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02843-w","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No author has any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Osaka University Medical Hospital (Approval No.: 15244-T10).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for participation in this study was obtained as part of a broad consent agreement approved by the institutional review board of Osaka University. This consent covered the use of participants\u2019 medical records and biological samples for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and registration number of the study\/trial"}}]}}